Question: Cancer genomics and NGS
gravatar for mst
19 months ago by
mst0 wrote:


I'm reading about cancer genomics and for better understanding of the subject decided to perform several numerical experiments. There are several naive questions that I would like to ask:

1) De novo assembly vs reads alignment - what is the preferred approach to assemble the whole tumor/normal genomes?

2) Is there any 'reads' simulator that allows to simulate cancer's genomes (with different types of aberrations, not only SNV) base on a reference one?

Thanks a lot, Maxim

sequencing assembly • 682 views
ADD COMMENTlink modified 19 months ago by Chris Miller19k • written 19 months ago by mst0
gravatar for Chris Miller
19 months ago by
Chris Miller19k
Washington University in St. Louis, MO
Chris Miller19k wrote:

1) Alignment and assembly are two very different concepts, so this isn't really an answerable question.


ADD COMMENTlink written 19 months ago by Chris Miller19k

Chris, thanks a lot for the link. By "reads alignment" I meant re-sequencing. So I thought to take a tool like bowtie, human reference genome and re-sequence "normal" genome of a donor. Then using this genome as a reference, re-sequence tumor genome of the same donor. Is it a correct route?

ADD REPLYlink written 19 months ago by mst0

You would benefit from reading some review articles on cancer genomics to get your terminology straight. Yes, the basic principle is to sequence both tumor and normal genomes from an individual, align them to the human reference, and compare the results to find somatic mutations

ADD REPLYlink written 19 months ago by Chris Miller19k

With the caveat that cancer genomes can be rearranged and have large CNVs.

Maybe this is why there is confusion regarding de novo assembly?

Some studies assemble cancer genomes de novo and map to that, rather than the normal reference.

ADD REPLYlink written 19 months ago by jotan1.1k

I'm still thinking about de novo/re-sequencing approaches. As I've read there could be different types of structural variations in cancer genomes, including inversions. Would it be useless to try assembly such genomes using re-sequencing?

ADD REPLYlink written 18 months ago by mst0
Please log in to add an answer.


Use of this site constitutes acceptance of our User Agreement and Privacy Policy.
Powered by Biostar version 2.3.0
Traffic: 1028 users visited in the last hour